[1]CHEN W,XIA C,ZHENG R,et al.Disparities by province,age,and sex in site-specific cancer burden attributable to 23 potentially modifiable risk factors in China:A comparative risk assessment[J].Lancet Glob Health,2019,7(2):e257-e269.
[2]H SUNG,J FERLAY,RL SIEGEL,et al.Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2021,71(3):209-249.
[3]中华人民共和国国家卫生健康委员会医政司.原发性肝癌诊疗指南(2024年版)[J].中国普通外科杂志,2024,33(04):475-530.Department of Medical Administration,National Health Commission of the People’s Republic of China.Clinical Practice Guideline for Primary Liver Cancer (2024 Edition)[J].China Journal of General Surgery,2024,33(04):475-530.
[4]JA NICOLAS-AVILA,JM ADROVER,A HIDALGO.Neutrophils in homeostasis,immunity,and cancer[J].Immunity,2017,46(1):15-28.
[5]HE G,ZHANG H,ZHOU J,et al.Peritumoural neutrophils negatively regulate adaptive immunity via the PD-L1/PD-1 signalling pathway in hepatocellular carcinoma[J].J Exp Clin Cancer Res,2015,34(141):1-11.
[6]XUE R,ZHANG Q,CAO Q,et al.Liver tumour immune microenvironment subtypes and neutrophil heterogeneity[J].Nature,2022,612(7938):141-147.
[7]徐馨,张岚,易清平,等.炎症预后指数对经导管肝动脉化疗栓塞术治疗肝癌疗效的评估价值[J].现代肿瘤医学,2022,30(17):3147-3150.XU X,ZHANG L,YI QP,et al.Evaluation value of inflammation prognosis index in transcatheter hepatic artery chemoembolization for liver cancer[J].Modern Oncology,2022,30(17):3147-3150.
[8]LIANG F,ZHANG H,GAO H,et al.Diagnostic value of peripheral blood NLR combined with serum AFP,GP73 and DKK1 in primary hepatocellular carcinoma[J].Modern Oncology,2021,29(6):989-993.
[9]ZHOU SL,ZHOU ZJ,HU ZQ,et al.Tumor-associated neutrophils recruit macrophages and T-regulatory cells to promote progression of hepatocellular carcinoma and resistance to sorafenib[J].Gastroenterology,2016,150(7):1646-1658.e1617.
[10]KUANG DM,ZHAO Q,WU Y,et al.Peritumoral neutrophils link inflammatory response to disease progression by fostering angiogenesis in hepatocellular carcinoma[J].J Hepatol,2011,54(5):948-955.
[11]WANG L,LIU Y,DAI Y,et al.Single-cell RNA-seq analysis reveals BHLHE40-driven pro-tumour neutrophils with hyperactivated glycolysis in pancreatic tumour microenvironment[J].Gut,2023,72(5):958-971.
[12]AJ MCFARLANE,F FERCOQ,SB COFFELT,et al.Neutrophil dynamics in the tumor microenvironment[J].J Clin Invest,2021,131(6):e143759.
[13]ANDREW R SAS, KEVIN S CARBAJAL, ANDREW D,et al.A new neutrophil subset promotes CNS neuron survival and axon regeneration[J].Nat Immunol,2020,21(12):1496-1505.
[14]HM MCGETTRICK.Bridging the gap-immune cells that can repair nerves[J].Cell Mol Immunol,2021,18(4):784-786.
[15]E RAMON-GIL,D GEH,J LESLIE.Harnessing neutrophil plasticity for HCC immunotherapy[J].Essays Biochem,2023,67(6):941-955.
[16]CHEN H,ZHOU XH,LI JR,et al.Neutrophils:Driving inflammation during the development of hepatocellular carcinoma[J].Cancer Lett,2021,522(x):22-31.
[17]LI L,XU L,YAN J,et al.CXCR2-CXCL1 axis is correlated with neutrophil infiltration and predicts a poor prognosis in hepatocellular carcinoma[J].J Exp Clin Cancer Res,2015,34(129):1-10.
[18] TEIJEIRA,S GARASA,M GATO,et al.CXCR1 and CXCR2 chemokine receptor agonists produced by tumors induce neutrophil extracellular traps that interfere with immune cytotoxicity[J].Immunity,2020,52(5):856-871.e858.
[19]R FETIT,AS MCLAREN,M WHITE,et al.Characterizing neutrophil subtypes in cancer using scRNA sequencing demonstrates the importance of IL1beta/CXCR2 axis in generation of metastasis-specific neutrophils[J].Cancer Res Commun,2024,4(2):588-606.
[20]D GUIMARAES-BASTOS,AC FRONY,C BARJA-FIDALGO,et al.Melanoma-derived extracellular vesicles skew neutrophils into a pro-tumor phenotype[J].J Leukoc Biol,2022,111(3):585-596.
[21]J LESLIE,JBG MACKEY,T JAMIESON,et al.CXCR2 inhibition enables NASH-HCC immunotherapy[J].Gut,2022,71(10):2093-2106.
[22]SAC MCDOWELL,S MILETTE,S DORE,et al.Obesity alters monocyte developmental trajectories to enhance metastasis[J].J Exp Med,2023,220(8):e20220509.
[23]S SAFARULLA,A MADAN,F XING,et al.CXCR2 mediates distinct neutrophil behavior in brain metastatic breast tumor[J].Cancers (Basel),2022,14(3):515-536.
[24]J YANG,L JIN,HS KIM,et al.KDM6A loss recruits tumor-associated neutrophils and promotes neutrophil extracellular trap formation in pancreatic cancer[J].Cancer Res,2022,82(22):4247-4260.
[25]LIU Y,YAO R,SHI Y,et al.Identification of CD101 in glioma:A novel prognostic indicator expressed on M2 macrophages[J].Front Immunol,2022,13(x):845223.
[26]R SCHEY,H DORNHOFF,JL BAIER,et al.CD101 inhibits the expansion of colitogenic T cells[J].Mucosal Immunol,2016,9(5):1205-1217.